NEW YORK ( TheStreet) -- CHANGE IN RATINGS
TD Ameritrade (AMTD) downgraded at Citigroup to Neutral from Buy, Citigroup said. Retail trading re-engagement risks re-ignite.
Boeing (BA) upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $80 price target. Aerospace cycle remains strong.
Buckeye Technologies (BKI) upgraded at UBS to Buy from Neutral, UBS said. $36 price target. Risks are higher, but sell off seems overdone.Cummins (CMI) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Company is leveraged to a likely NAFTA truck inventory correction later this year. Facebook (FB) rated new Underperform at Bernstein. $25 price target. Company will likely struggle to achieve sales growth targets. Huntington Bancshares (HBAN) downgraded at FBR from Market Perform to Underperform, FBR Capital Markets said. $6 price target. Company is leveraged to lower interest rates. HealthSouth (HLS) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call. KAR Auction (KAR) upgraded at Baird to Outperform, Robert Baird said. Valuation call, based on a $21 price target. NY Community Bancorp (NYB) downgraded at FBR. NYB was downgraded from Outperform to Market Perform, FBR Capital Markets said. $13.50 price target. Estimates also cut, given lower expected net interest margin. PG&E (PCG) rated new Equal-weight at Morgan Stanley. $47 price target. Risk/reward is neutral at cuirrent levels. Pioneer Natural (PXD) upgraded at Societe Generale from Sell to Hold, Societe Generale said. Valuation call, based on a $92 price target. Regions Financial (RF) downgraded at Morgan Stanley from Buy to Hold, Morgan Stanley said. $6.50 price target. Company is leveraged to slower macro growth and lower interest rates. Charles Schwab (SCHW) downgraded at Citigroup to Neutral from Buy, Citigroup said. Retail trading re-engagement risks re-ignite. Zions Bancorporation (ZION) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $21 price target. Company needs to cut costs, to cope with the lower interest rate environment.
STOCK COMMENTS / EPS CHANGESExpress Scripts (ESRX) numbers lowered at BMO through 2013, BMO Capital said. Company is facing higher debt costs, following the Medco merger. Market Perform rating and new $50 price target.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV